Ballentine Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.59M | Buy |
33,436
+175
| +0.5% | +$18.8K | 0.05% | 119 |
|
|
2025
Q1 | $3.36M | Buy |
33,261
+1,625
| +5% | +$164K | 0.06% | 115 |
|
|
2024
Q4 | $2.83M | Buy |
31,636
+2,248
| +8% | +$201K | 0.05% | 133 |
|
|
2024
Q3 | $2.46M | Sell |
29,388
-2,452
| -8% | -$205K | 0.04% | 148 |
|
|
2024
Q2 | $2.45M | Buy |
31,840
+4,779
| +18% | +$368K | 0.05% | 134 |
|
|
2024
Q1 | $1.85M | Buy |
27,061
+1,993
| +8% | +$137K | 0.04% | 162 |
|
|
2023
Q4 | $1.45M | Buy |
25,068
+1,059
| +4% | +$61.2K | 0.03% | 185 |
|
|
2023
Q3 | $1.27M | Buy |
24,009
+139
| +0.6% | +$7.34K | 0.03% | 172 |
|
|
2023
Q2 | $1.29M | Buy |
23,870
+770
| +3% | +$41.6K | 0.03% | 170 |
|
|
2023
Q1 | $1.16M | Buy |
23,100
+4,652
| +25% | +$233K | 0.03% | 181 |
|
|
2022
Q4 | $854K | Buy |
18,448
+10,100
| +121% | +$467K | 0.03% | 187 |
|
|
2022
Q3 | $323K | Buy |
8,348
+2,337
| +39% | +$90.4K | 0.01% | 324 |
|
|
2022
Q2 | $224K | Buy |
6,011
+107
| +2% | +$3.99K | 0.01% | 376 |
|
|
2022
Q1 | $261K | Sell |
5,904
-497
| -8% | -$22K | 0.01% | 382 |
|
|
2021
Q4 | $273K | Buy |
6,401
+873
| +16% | +$37.2K | 0.01% | 380 |
|
|
2021
Q3 | $240K | Buy |
5,528
+36
| +0.7% | +$1.56K | 0.01% | 367 |
|
|
2021
Q2 | $235K | Sell |
5,492
-188
| -3% | -$8.04K | 0.01% | 372 |
|
|
2021
Q1 | $219K | Buy |
+5,680
| New | +$219K | 0.01% | 361 |
|
|
2020
Q4 | – | Sell |
-8,970
| Closed | -$343K | – | 390 |
|
|
2020
Q3 | $343K | Buy |
8,970
+161
| +2% | +$6.16K | 0.02% | 263 |
|
|
2020
Q2 | $309K | Sell |
8,809
-1,525
| -15% | -$53.5K | 0.01% | 266 |
|
|
2020
Q1 | $336K | Sell |
10,334
-955
| -8% | -$31.1K | 0.02% | 233 |
|
|
2019
Q4 | $510K | Buy |
11,289
+104
| +0.9% | +$4.7K | 0.02% | 224 |
|
|
2019
Q3 | $455K | Hold |
11,185
| – | – | 0.02% | 217 |
|
|
2019
Q2 | $481K | Buy |
11,185
+1,974
| +21% | +$84.9K | 0.02% | 217 |
|
|
2019
Q1 | $354K | Buy |
9,211
+148
| +2% | +$5.69K | 0.02% | 228 |
|
|
2018
Q4 | $320K | Buy |
9,063
+2,758
| +44% | +$97.4K | 0.02% | 231 |
|
|
2018
Q3 | $243K | Buy |
6,305
+176
| +3% | +$6.78K | 0.01% | 293 |
|
|
2018
Q2 | $201K | Buy |
+6,129
| New | +$201K | 0.01% | 317 |
|